Literature DB >> 16481509

Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice.

Masako Andoh1, Kasi E Russell-Lodrigue, Guoquan Zhang, James E Samuel.   

Abstract

Coxiella burnetii has two phase variants: highly virulent phase I and avirulent phase II. To examine the differences between the two phase variants in interaction with host response to infection, we performed experimental infection in immunodeficient mice. Experimental C. burnetii phase I infection in SCID mice suggested that innate immunity cannot control replication of the bacteria and that acquired immunity is essential for mice to survive infection. In this study, we used SCID and SCIDbg mice to determine whether phase II bacterial infection can be controlled in vivo.

Entities:  

Mesh:

Year:  2005        PMID: 16481509     DOI: 10.1196/annals.1355.026

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii.

Authors:  Amanda J Read; Sara Erickson; Allen G Harmsen
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

Review 2.  Animal models of Q fever (Coxiella burnetii).

Authors:  Kevin R Bewley
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

3.  The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.

Authors:  Aminul Islam; Michelle Lockhart; John Stenos; Stephen Graves
Journal:  Am J Trop Med Hyg       Date:  2013-08-19       Impact factor: 2.345

4.  Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium.

Authors:  Anders Omsland; Paul A Beare; Joshua Hill; Diane C Cockrell; Dale Howe; Bryan Hansen; James E Samuel; Robert A Heinzen
Journal:  Appl Environ Microbiol       Date:  2011-04-08       Impact factor: 4.792

5.  Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice.

Authors:  Teske Schoffelen; Joshua S Self; Kelly A Fitzpatrick; Mihai G Netea; Marcel van Deuren; Leo A B Joosten; Gilbert J Kersh
Journal:  Diagn Microbiol Infect Dis       Date:  2014-12-30       Impact factor: 2.803

6.  Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.

Authors:  Reginaldo G Bastos; Zachary P Howard; Aoi Hiroyasu; Alan G Goodman
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

7.  Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.

Authors:  Javier Ochoa-Repáraz; Jami Sentissi; Theresa Trunkle; Carol Riccardi; David W Pascual
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

8.  Major Histocompatibility Complex Class II-Restricted, CD4+ T Cell-Dependent and -Independent Mechanisms Are Required for Vaccine-Induced Protective Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

9.  Identification of OmpA, a Coxiella burnetii protein involved in host cell invasion, by multi-phenotypic high-content screening.

Authors:  Eric Martinez; Franck Cantet; Laura Fava; Isobel Norville; Matteo Bonazzi
Journal:  PLoS Pathog       Date:  2014-03-20       Impact factor: 6.823

10.  Human dose response relation for airborne exposure to Coxiella burnetii.

Authors:  Russell John Brooke; Mirjam E E Kretzschmar; Nico T Mutters; Peter F Teunis
Journal:  BMC Infect Dis       Date:  2013-10-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.